Cat. No. | Product name | CAS No. |
DCC2002 |
Errα Degrader-1
Novel PROTAC Estrogen-related Receptor α (ERRα) Degrader |
2306388-84-9 |
DCC2003 |
Erso-dfp
Novel Activator of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer |
|
DCC2004 |
Erß Nir Probe P5
The first ERβ-targeted near-infrared (NIR) inherently fluorescent probe, showing the advantages of high ERβ selectivity, good optical properties, and excellent ERβ imaging capability in living cells |
|
DCC2005 |
Ertapenem Disodium
Carbapenem antibiotic, inhibiting cross-linking of the peptidoglycan layer of bacterial cell walls by blocking penicillin-binding proteins (PBPs) |
153832-38-3 |
DCC2006 |
Erthermac
Novel thermosensitive fluorescent dye, visualizing thermogenesis in stimulated single-cell brown adipocytes |
|
DCC2007 |
Er-thermo-yellow
The First Fluorescent Probe for Targeted Visualization of Temperature at the Endoplasmic Reticulum #222222; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.17px; text-align: start; text-in |
1445108-32-6 |
DCC2008 |
Erw1041e
Novel potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the close related enzyme TG1 |
|
DCC2009 |
Erythrocentaurin
Anti-HBV agent, showing activities on HepG 2.2.15 cell line in vitro |
50276-98-7 |
DCC2010 |
Erythro-di-o-benzyl Droxidopa Hcl
Precursor of adrenaline, suppressing the locomotor stimulation by MAO inhibitor |
73594-44-2 |
DCC2011 |
Erythromycin Ethylsuccinate
Broad-spectrum, topical macrolide antibiotic, diffusing through the bacterial cell membrane and reversibly binding to the 50S subunit of the bacterial ribosome |
1264-62-6 |
DCC2012 |
escaline Hydrochloride
Serotonin 5-HT2A Agonist |
3166-82-3 |
DCC2013 |
Est64454
Novel Highly Soluble σ1 Receptor Antagonist for Pain Management |
|
DCC2014 |
Estetrol
Selective estrogen receptor modulator (SERM), exhibiting estrogen agonism in certain tissues and estrogen antagonism in others |
15183-37-6 |
DCC2015 |
Cgs-27023a
Non-Peptidic, potent, and orally active stromelysin inhibitor, blocking cartilage degradation |
161314-70-1 |
DCC2016 |
Etb067
H-89 analog as PKA and AKT1 inhibitor with specificity on no longer inhibiting CAMK2B and neither affecting viability of mice nor causing any detectable tissuedamage at the dose given |
1000995-79-8 |
DCC2017 |
Etc-131
Novel inhibitor of PORCN, inhibiting ß-catenin reporter activity in a dose-dependent manner |
|
DCC2018 |
Ethd-1
Cell-impermeant viability indicator, as high-affinity nucleic acid stain that is weakly fluorescent until bound to DNA and emits red fluorescence (excitation/emission maxima ~528/617). |
61926-22-5 |
DCC2019 |
Etheofazine
Novel anticancer agent |
85609-79-6 |
DCC2020 |
Ethyl 3-hydroxyhexanoate
Natural potent antiviral agent, significantly inhibiting coxsackievirus group B (CVB) replication both in vivo and in vitro |
2305-25-1 |
DCC2021 |
Ethyl Lipotf
Novel selective FTO inhibitor |
1808089-27-1 |
DCC2022 |
Ethylvanillin
TRPA1 channel agonist |
121-32-4 |
DCC2023 |
Etifoxine
Activator of β2 and β3 subunit containing channels of the GABAA receptor complex, stimulating the production of GABA(A) active neurosteroids |
21715-46-8 |